ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I

ClinicalTrials.gov ID: NCT00661453

Public ClinicalTrials.gov record NCT00661453. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 9:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I/II Trial of Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy Type I (CARNI-VAL Type I)

Study identification

NCT ID
NCT00661453
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
University of Utah
Other
Enrollment
40 participants

Conditions and interventions

Interventions

  • Valproic Acid and Levocarnitine Drug

Drug

Eligibility (public fields only)

Age range
2 Weeks to 12 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2008
Primary completion
Apr 30, 2012
Completion
May 31, 2012
Last update posted
Jun 14, 2015

2008 – 2012

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
Johns Hopkins University Baltimore Maryland 21287
Children's Hospital of Michigan Detroit Michigan 48201
Duke University Medical Center Durham North Carolina 27710
Ohio State University Medical Center, Dept. of Neurology Columbus Ohio 43210
University of Utah/Primary Children's Medical Center Salt Lake City Utah 84132
University of Wisconsin Children's Hospital Madison Wisconsin 53792-9988

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00661453, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 14, 2015 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00661453 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →